Ditchcarbon
  • Contact
  1. Organizations
  2. Bio Products Laboratory Ltd.
Public Profile
Pharmaceutical Preparation Manufacturing
GB
updated a month ago

Bio Products Laboratory Ltd.

Company website

Bio Products Laboratory Ltd. (BPL) is a leading biopharmaceutical company headquartered in the United Kingdom. Established in 1983, BPL has made significant strides in the development and manufacture of high-quality plasma-derived therapies, primarily serving patients with rare and chronic conditions. With operational facilities in the UK and a growing presence in international markets, BPL is committed to advancing healthcare through innovative solutions. The company’s core products include immunoglobulins, clotting factors, and albumin, all distinguished by their rigorous quality standards and commitment to patient safety. BPL's dedication to research and development has positioned it as a trusted partner in the biopharmaceutical industry, recognised for its contributions to patient care and its robust pipeline of therapies. With a focus on excellence and innovation, Bio Products Laboratory Ltd. continues to enhance its market position and deliver impactful healthcare solutions globally.

DitchCarbon Score

How does Bio Products Laboratory Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Bio Products Laboratory Ltd.'s score of 23 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.

36%

Let us know if this data was useful to you

Bio Products Laboratory Ltd.'s reported carbon emissions

In 2023, Bio Products Laboratory Ltd. reported carbon emissions data indicating approximately 6,000 kg CO2e per unit of revenue. This figure reflects their Scope 2 location-based emissions, although specific Scope 1 and Scope 3 emissions data were not disclosed. The company operates under a revenue of about USD 546,359,000. Currently, Bio Products Laboratory Ltd. has not set any specific reduction targets or initiatives, nor do they participate in recognised climate pledges such as the Science Based Targets initiative (SBTi). Their emissions data is cascaded from their parent organization, indicating a corporate family relationship, but no specific details on the source organization were provided. As a current subsidiary, Bio Products Laboratory Ltd. is positioned within an industry context that increasingly prioritises carbon reduction and sustainability. However, without defined targets or commitments, their climate strategy remains unclear.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Bio Products Laboratory Ltd.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Bio Products Laboratory Ltd. is in GB, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Bio Products Laboratory Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Biotest Pharmaceuticals Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 15 days ago

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Biogen

US
•
Pharmaceutical Preparation Manufacturing
Updated about 7 hours ago

Takeda

JP
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Csl

AU
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251024.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy